Micro-( 5 mm) and nanoplastics ( 1 μm) are emerging threats for marine ecosystems worldwide. Brine shrimp Artemia is recognized as a suitable model among planktonic species for studying the impact of polystyrene nanoparticles (PS NPs) through short and long-term bioassays. Our study aims to evaluate the timedependent effects of cationic amino-modified PS-NH 2 (50 nm) in A. franciscana after short-(48 h) and long-term exposure (14 days). For this purpose, nauplii were exposed to a concentration range of PS-NH 2 (0.1, 1, 3 and 10 µg/mL) in natural sea water (NSW), and physiological, biochemical and molecular responses were investigated. Short-term exposure to PS-NH 2 caused a decrease in nauplii growth and affected the development in a concentration-dependent manner, long-term exposure impaired the survival, but not the growth and feeding behavior. Oxidative stress was detected after short term exposure as the decrease in the activity of antioxidant enzymes, and was fully evident in the long-term as lipid peroxidation, suggesting an accumulative effect. The decrease in Cholinesterase (ChE) activity observed indicates possible neurotoxic action of PS-NH 2. Also, Carboxylesterase (CbE) inhibition by PS-NH 2, described for the first time in this study, anticipates potential effects in biotransformation of exogenous and endogenous compounds, being the crustacean juvenile hormone methyl farnesoate (MF) that regulates development and molting, one candidate. Furthermore, short-and long-term exposure to PS-NH 2 affect the expression of genes involved in cell protection, development and molting. Overall, our results reveal that low PS-NH 2 concentrations induce physiological, biochemical and molecular (changes in gene expression) alterations in Artemia, and point at their potential risk for this model organism, supporting the general concern about nanoplastics occurrences in aquatic environments and their ability to represent an ecological threat for aquatic zooplanktonic species.
The common octopus (Octopus vulgaris, Cuvier 1797) is a promising species for aquaculture diversification, but the massive mortality during the first life stage is the main bottleneck for its commercial production. The aim of the present study was to compare the effects of different live preys (Artemia and crustacean zoeae) and/or Artemia enrichment protocols in the paralarval growth by using a meta‐analysis approach. A total of 26 independent assays were used, including data from the bibliography and from experiments carried out by our group. Three comparisons were established: (i) crustacean zoeae vs. Artemia, (ii) different crustacean zoeae species and (iii) Artemia enriched with marine lecithin (rich in polar lipids‐PL and docosahexaenoic acid‐DHA) vs. previously used Artemia enrichments. The meta‐analysis approach allowed a quantitative review of independent studies with reliable conclusions, avoiding the subjectivity inherent to classical reviews. The outputs provided statistical confirmation of the better suitability of crustacean zoeae with respect to Artemia. However, not all crustacean species showed the same results, given that the high variability on Grapsus zoeae hampered finding significant differences with respect to the control treatment (Artemia). Nutrient composition and biometry of the different types of prey are discussed as possible causes of the differences arising from the meta‐analysis. Finally, the present results suggest that marine lecithin has a beneficial effect on paralarval growth with respect to previously used enrichments, which could be related to the increase in DHA and PL in Artemia, given the essential role of these lipid components in octopus paralarval physiology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.